Page last updated: 2024-10-23

benzethonium and Chronic Disease

benzethonium has been researched along with Chronic Disease in 1 studies

Benzethonium: Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Serena, T1
Connell, H1
McConnell, S1
Patel, K1
Doner, B1
Sabo, M1
Miller, M1
Serena, L1
Le, LT1
Goldsmith, D1
Chung, J1

Other Studies

1 other study available for benzethonium and Chronic Disease

ArticleYear
Novel Multivalent Wound-Healing Ointment Provides Bioburden Control and Moisture Management: A Retrospective Registry Data Analysis.
    Advances in skin & wound care, 2016, Volume: 29, Issue:10

    Topics: Administration, Topical; Aged; Aged, 80 and over; Ambulatory Care; Benzethonium; Chronic Disease; Di

2016